Back to Search
MATTHEW HARDEE, M.D., PH.D.
M.D., PH.D.
Radiation Oncology Physician
NPI: 1487896973IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
E-7372(AR)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 2007
Research & Publications (8)
Novel imaging provides new insights into mechanisms of oxygen transport in tumors.
PMID 19519401·Curr Mol Med·2009
6-review
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.
PMID 18365198·Cancer Chemother Pharmacol·2009
7-preclinical
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
PMID 17579721·PLoS One·2007
7-preclinical
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
PMID 16505109·Mol Cancer Ther·2006
7-preclinical
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.
PMID 16288305·Br J Cancer·2005
7-preclinical
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer.
PMID 19578493·Biomark Insights·2008
8-other
The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma.
PMID 16518899·Radiat Res·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8901 CARTI WAY
LITTLE ROCK, AR 72205 - Phone
- (501) 296-3247
Quick Facts
- NPI
- 1487896973
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 8
Are you this provider?
Claim Your Profile